![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37551-37558, December 31, 1999
§,
,
§§
From the
Division of Respiratory Medicine, Department
of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada,
the ¶ Division of Gastroenterology, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, the
§ Division of Cell Biology, Research Institute, The Hospital
for Sick Children, Toronto, Ontario M5G 1X8, Canada, and the

Department of Physiology, McGill
University, Montréal, Québec, H3G 1Y6, Canada
| |
ABSTRACT |
|---|
|
|
|---|
Trafficking of the
Na+/H+ exchanger isoform 3 (NHE3) between
sub-apical vesicles and apical membrane of epithelial cells is a
suggested mechanism of regulation of NHE3 activity. When epitope-tagged NHE3 was stably expressed in NHE-deficient Chinese hamster ovary cells,
a sizable fraction was found in recycling endosomes. This system was
used to analyze the mechanism of endocytosis of NHE3. Immunofluorescence and radiolabeling experiments showed that inhibition of clathrin-mediated endocytosis using hypertonicity, acid treatment, or K+ depletion inhibited internalization of NHE3.
Moreover, transient transfection of an inhibitory mutant of dynamin
(DynS45N) blocked the clathrin-mediated uptake of transferrin, as well
as the endocytosis of NHE3. In ileal villus cells, endogenous NHE3 was
also found to co-purify with isolated clathrin-coated vesicles, thereby
confirming their association in native tissues. The role of COP-I
subunits in the intracellular traffic of NHE3 was evaluated using
ldlF cells, which bear a temperature-sensitive mutation in
the The Na+/H+ exchangers
(NHE)1 are a family of
integral membrane proteins that translocate Na+ in exchange
for H+ across the cell surface and mitochondrial membranes.
Na+/H+ exchange is electroneutral and is
therefore driven by the combined chemical gradients of Na+
and H+. NHE plays an important role in the maintenance of
intracellular pH (pHi) and in the regulation of cell volume. In
epithelial cells, where the exchangers are particularly abundant, they
are essential for the vectorial transport of salt and water. To date, six mammalian NHE isoforms have been identified (reviewed in Ref. 1).
NHE1 is widely expressed and is generally considered to be the
"housekeeping" isoform primarily responsible for pHi homeostasis. NHE2-5 have a more restricted tissue distribution, whereas NHE6 is ubiquitous and present in mitochondria. Of these, NHE2
and NHE3 are predominantly epithelial isoforms, which are highly
expressed in the gastrointestinal tract and kidney (2-4), where they
are thought to be important for Na+, bicarbonate and water
(re)absorption (5-7).
Multiple NHE isoforms can co-exist in epithelial cells, where they are
segregated to distinct subcellular domains. NHE1 is located almost
entirely in the basolateral side of the cell (8, 9), whereas NHE2 has
been reported to be present in both apical and basolateral membranes
(10-12). By contrast, NHE3 is exclusively targeted to the apical
domain of the cells (13-15). Interestingly, unlike NHE1 and NHE2 which
are expressed primarily at the plasma membrane, immunolocalization
experiments have revealed a significant intracellular pool of NHE3. In
native epithelia (16) as well as in cultured epithelial cells (11-13),
NHE3 was detectable not only at the cell surface, but also in a
population of subapical vesicles. These direct immunolocalization
studies confirmed earlier suggestions that NHE was also present and
functional in endomembranes. Fractionation studies in conjunction with
either transport (17-19) or immunological assays (20, 21) had
previously found that NHE was detectable in membranes other than the
plasmalemma. Na+/H+ exchange in these
endomembranes was reported to be amiloride-resistant (19), a
characteristic of the NHE3 isoform.
An intracellular pool of antiporters may provide a source for the rapid
mobilization of transporters to the plasma membrane in response to
stimulation, thereby affording the cell a powerful and versatile
mechanism for regulating NHE3 activity. Indeed, chronic acidosis,
prolonged hyperosmolarity, and responsiveness to angiotensin II have
been shown to increase plasmalemmal NHE3 activity, with minimal
increase in mRNA expression (22-24). Shuttling of NHE3 between the
plasmalemmal and endosomal pools may well be responsible for this
effect. Despite the apparent importance of NHE3 internalization and
recycling, little is known about the underlying mechanisms. This is due
in large part to the difficulties involved in discerning the internal
and superficial pools of NHE3 in epithelial systems, which are also
rather refractory to transfection.
The partition of NHE3 in an intracellular vesicular compartment was
replicated when NHE3 was heterologously transfected in Chinese hamster
ovary (CHO) cells (25). While exchangers were present and active at the
plasma membrane, a sizable fraction was found in a juxtanuclear
vesicular complex that co-localized with internalized transferrin and
with cellubrevin, hallmarks of the recycling endosomal compartment. By
transfecting a modified NHE3 bearing an external epitope, Kurashima
et al. (26) were able to quantify the fraction of exchangers
in endomembranes and to monitor their traffic. They found that NHE3 is
internalized continuously and that recycling to the surface is
responsible for maintaining a constant number of plasmalemmal transporters.
Several mechanisms are utilized to internalize plasma membrane
proteins, including clathrin-mediated coated vesicle formation (27),
generation of caveolae (28, 29), or other uncoated vesicles (28, 30),
and actin-dependent macropinocytosis. The pathway(s)
utilized by NHE3 have not been defined. The purpose of the current
study was to identify the mechanism(s) that mediate NHE3
internalization and to analyze the factors required for recycling of
the internalized exchangers to the plasma membrane. To this end, we
used cells heterologously transfected with rat NHE3 that was externally
tagged with a triple HA epitope. Pharmacological and transfection
experiments indicate that NHE3 is largely internalized via
clathrin-coated pits and vesicles. The presence of NHE3 in coated
vesicles was confirmed in intestinal cells from rabbits, implying that
clathrin is also involved in NHE3 internalization in native epithelia.
Materials and Media--
Nigericin, rhodamine-conjugated human
transferrin (Tfn), and the acetoxymethyl ester of
2'7'-bis-(2-carboxyethyl)-5(and 6)-carboxyfluorescein (BCECF) were purchased from Molecular Probes, Inc. (Eugene, OR). The
plasmid containing the enhanced green fluorescent protein (pEGFP) was
purchased from CLONTECH (Palo Alto, CA). Monoclonal antibodies to clathrin, adaptor proteins 1 and 2 (AP-1 and AP-2), and
all other chemicals were purchased from Sigma. Monoclonal antibodies
recognizing the heavy chain of clathrin and the influenza virus HA
epitope (YPYDVPDYAS) were from ICN and Babco (Richmond, CA),
respectively. The anti-NHE3 antibody (Clone 2B9) was a kind gift from
Dr. D. Biemesderfer (Yale University School of Medicine, New Haven,
CT). Goat anti-mouse and anti-rabbit Cy3-labeled IgG were purchased
from Jackson Laboratories and goat anti-mouse I125-labeled
IgG from ICN (Costa Mesa, CA). Ficoll 400 was from Amersham Pharmacia
Biotech, and sucrose was from Fisher.
Phosphate-buffered saline (PBS) contained (in mM): 140 NaCl, 10 KCl, 8 sodium phosphate, 2 potassium phosphate, pH 7.4. Na+-rich solution contained (in mM): 117 NaCl,
1.66 MgSO4, 1.36 CaCl2, 5.36 KCl, 25 HEPES,
5.55 glucose. Na+-free,
N-methyl-D-glucammonium solution was made by
equimolar substitution of NaCl by
N-methyl-D-glucammonium-Cl. All solutions were
nominally bicarbonate-free, titrated to pH 7.4, and were adjusted to
290 ± 10 mosM with the major salt.
Cell Lines--
AP-1 is a cell line derived from wild-type CHO
cells that are devoid of endogenous Na+/H+
exchanger activity (31). AP1/NHE3'38HA3 cells are AP-1
cells stably transfected with rat NHE3 containing a triple HA tag in the first extracellular loop following residue 38 (26). ldlF cells, a gift from Dr. M. Krieger (Massachusetts Institute of Technology, Cambridge, MA), are CHO cells that have a
temperature-sensitive mutation in
AP1/NHE3'38HA3 cells and ldlF cells were grown
in Transfection--
The cDNAs encoding wild-type dynamin I and
the S45N mutant (DynS45N) subcloned into the pcDNA3 vector were a
gift of Dr. S. Schmid (Scripps Institute, La Jolla, CA). To facilitate
detection by immunostaining, both dynamin constructs were HA-tagged at
the amino terminus. Rat NHE3'38HA3 subcloned into the pCMV
vector has been described previously (26). All vectors were transformed into DH5
For transient expression experiments, cells were grown to 30-40%
confluence on 25-mm glass coverslips. The vectors of interest were
co-transfected with pEGFP at a 10:1 ratio, which enabled us to
positively identify the transfectants. All cells were transfected at
37 °C, with the exception of the ldlF cells, which where
maintained at the permissive temperature of 34 °C throughout the
transfection protocol. Immunofluorescence and microfluorimetry were
performed 24-48 h post-transfection.
Inhibition of Clathrin-mediated Endocytosis--
Three different
procedures were used to prevent clathrin-mediated endocytosis.
Hypertonic challenge was performed according to Hansen et
al. (35). Briefly, the normal growth medium was replaced with
HEPES-buffered medium supplemented with 0.45 M sucrose for
15 min at 37 °C, prior to estimation of NHE3 distribution. A second
procedure, involving depletion of intracellular K+, was
modified from Hansen et al. (35, 36). Cells were washed three times with K+-free medium (140 mM NaCl,
20 mM HEPES, 1 mM CaCl2, 1 mM MgCl2 and 1 g/liter D-glucose),
then shocked for 5 min with hypotonic K+-free solution (1:1
K+-free medium:H2O) at room temperature. Cells
were washed 3-fold with K+-free medium and allowed to
incubate in the same medium for an additional 15 min at 37 °C. Acid
treatment was also used to inhibit clathrin-mediated endocytosis (35).
In this case the cells were treated with Na+ medium
supplemented with 5 mM acetic acid, pH 5.0, for 10 min at
room temperature prior to the assay, which was carried out in the same medium.
Immunofluorescence--
To localize total NHE3 or to verify the
expression of dynamin by immunofluorescence, the cells were washed
three times with PBS prior to fixation with 4% paraformaldehyde. The
cells were then incubated with 100 mM glycine in PBS for 15 min and permeabilized with 0.1% Triton X-100 in PBS supplemented with
10% fetal bovine serum for 20 min. Incubation with anti-HA antibody
(1/1000) for 1 h at room temperature was followed by extensive
washes with PBS, blocking for 1 h with 10% goat serum, and then
incubating for 1 h with 1/1000 goat Cy3 anti-mouse antibody. The
coverslips were mounted using Dako Fluorescence Mounting Medium.
To assess internalization of the antiporter, intact
NHE3'38HA3-expressing cells were incubated for 45-60 min
at 37 °C with anti-HA antibody (1/1000) in HEPES-buffered medium
supplemented with 10% goat serum. Unbound antibody was removed by
extensive washes with cold PBS, and the cells were then fixed,
permeabilized, blocked, and labeled with Cy3-conjugated secondary
antibody as above. Where specified, incubation with the primary anti-HA
antibody was performed at 4 °C, followed by varying times of
internalization in the absence of added antibody.
To assess recycling of Tfn receptors, cells grown on 25-mm coverslips
were first incubated in serum-free HEPES-buffered medium for at least
30 min to deplete endogenous Tfn. Next, the cells were incubated with
20 µg/ml rhodamine-conjugated human Tfn for 45-60 min at 37 °C.
Unbound Tfn was washed extensively with PBS and the cells were fixed
for 45 min with 4% paraformaldehyde and mounted as described above.
Cells were visualized using the 100× objective of a Leica DM1RB
fluorescence microscope (Heidelberg, Germany) equipped with a Micromax
cooled CCD camera (Princeton Instruments, Trenton, NJ), operated from a
Dell computer using Winview software (Princeton Instruments). Digitized
images were cropped using Adobe Photoshop (Adobe Systems, Inc.). All
images are representative of at least three separate experiments.
Quantitation of NHE Internalization Using Radiolabeled
IgG--
Quantitation of recycling of NHE3'38HA3 was
performed using I125-labeled anti-mouse IgG.
AP1/NHE3'38HA3 cells were grown to 80-90% confluence on
six-well plastic dishes. The cells were then incubated at 4 °C for
1 h or at 37 °C for the time periods indicated with monoclonal
anti-HA antibody (1/1000) in medium supplemented with 10% goat serum.
Internalization was terminated by extensive washes with ice-cold PBS
wash buffer (PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2), and the preparation was
blocked by incubation with wash buffer supplemented with 10% goat
serum for 1 h at 4 °C. The cells were then labeled with mouse
I125-IgG (0.8 µCi/ml) for 1 h at
4 °C, followed by removal of unbound I125-IgG by
extensive washing with ice cold wash buffer. Last, the cells were
eluted from the culture dish with 1 ml of 2 M formic acid.
Cells exposed only to I125-IgG without prior incubation
with anti-HA antibody were used as background controls. Radioactivity
was counted using a 1282 Compugamma LKB Isolation of Clathrin-coated Vesicles--
Clathrin-coated
vesicles (CCV) were isolated from rabbit liver and from ileal villus
cells by differential centrifugation using a protocol adapted from
Campbell et al. (37, 38). This method initially yields crude
clathrin-coated vesicles that are ideally suited for further
purification using a sucrose gradient. Following this protocol, highly
enriched CCV (80-90% pure) are obtained (38). The major contaminants
are ferritin and some filamentous material (39). Ileal villus cells
were isolated by a modification of the method of Weiser (40) as
reported previously (41). All procedures for the purification of CCV
were done at 4 °C. The isolated cells were homogenized in 20 volumes
of buffer containing 0.1 M MES, 0.5 mM
MgCl2, 1 mM EGTA and 0.02% NaN3, pH 6.5 (buffer A), with protease inhibitors, using a Dounce
homogenizer. For isolation of CCV from liver, the tissue was
homogenized in the same buffer using a Polytron homogenizer. The
homogenate was centrifuged at 8000 × g for 50 min at
4 °C and the supernatant saved. The supernatant was sedimented at
186,000 × g for 60 min. The pellet was homogenized
with buffer A in a Potter-Elvehjem apparatus and mixed with an equal
volume of Ficoll-sucrose solution (both at a final concentration of
12.5% in buffer A, pH 6.5). The redissolved pellet was centrifuged at
40,000 × g for 40 min and the supernatant saved. The
pellet from this fraction was again resuspended in Ficoll-sucrose as
described above, centrifuged, and the supernatant saved. The
supernatants were pooled and mixed with 3-4 volumes of buffer A and
centrifuged at 186,000 × g for 60 min. The pellet
represented the CCV preparation. The pellet was resuspended in 1-2
volumes of buffer A layered on a discontinuous sucrose gradient (from
the bottom: 60%, 50%, 40%, 30%, 20%, 10%, 5%) and centrifuged at
50,000 × g for 2 h at 4 °C. Fractions were collected and analyzed by SDS-polyacrylamide gel electrophoresis followed by Coomassie blue staining and by immunoblotting. CCV were
enriched in the 10-20% fraction of the gradient.
Measurement of Intracellular pH--
Cytosolic pH was measured
in BCECF-loaded cells by either microfluorimetry or by ratio imaging,
essentially as described (25, 42). All measurements of pHi were
performed at 37 °C. Calibration of the fluorescence intensity to
pHi was performed in the presence of 5 µM
nigericin in high potassium medium (140 mM KCl, 20 mM HEPES, 1 mM MgCl2, and 5 mM glucose) as described previously (43). Each coverslip
was calibrated at the end of the experiment using at least three pH values.
Use of Anti-HA Antibodies to Probe NHE3 Distribution and
Function--
To facilitate the assessment of NHE3 traffic between the
plasmalemmal and intracellular pools, we inserted an HA epitope tag in
the predicted first extracellular loop of the protein (between residues
38 and 39). An extracellular epitope was essential to detect NHE3 in
intact (nonpermeabilized) cells and thereby quantify its rate and
extent of internalization. Using heterologous expression in
antiport-deficient AP-1 cells, we have shown that the insertion of the
HA tag in this position does not measurably alter the expression or ion
exchange properties of NHE3 (26). When expressed in AP1 cells, the
externally tagged exchanger, named NHE3'38HA3, was found to
accumulate in a pericentriolar compartment (Fig.
1A). This coincides with the
distribution of the carboxyl-terminal HA-tagged form of NHE3, which was
described earlier to reside in recycling endosomes (25). The similar
localization of the two forms of the exchanger implies that the
placement of epitope tags has little effect on NHE3 targeting.
Binding of anti-HA antibody to the external epitope was used next to
monitor the distribution of the exchangers. It was essential to
ascertain that the binding of antibody to NHE3 would not by itself
alter the behavior of the exchangers. The effect of the antibody on
NHE3 distribution was assessed first. NHE3'38HA3
transfectants were incubated with the antibody and the cells were then
incubated at 37 °C for 45 min to allow internalization to proceed.
The cells were then fixed, permeabilized, and labeled with secondary
antibodies. As illustrated in Fig. 1B, the distribution of
NHE3 resembles that observed in untreated cells which were fixed and
permeabilized prior to immunostaining (cf. Fig. 1,
A and B). Thus, binding of monoclonal antibody to
the extracellular epitope did not alter the subcellular distribution of
NHE3'38HA3, implying normal traffic within the cell.
We also determined whether the antibody alters
Na+/H+ exchange across the plasma membrane.
Cells were initially incubated in the cold in the presence or absence
of a concentration of antibody determined earlier to saturate all the
available extracellular epitope sites. Na+/H+
exchange activity was then estimated by microfluorimetric measurement of pHi using the pH-sensitive dye BCECF. Following an acute
acid load imposed by a 50 mM NH4Cl prepulse, we
measured the pHi recovery induced by superfusion with
Na+. Comparison of traces 1 and 2 in
Fig. 1C illustrates that engagement of the external epitope
by the antibody had no discernible effect on the rate of ion exchange
mediated by NHE3'38HA3.
While binding of antibody to the exchangers exposed at the surface had
little effect on their transport activity, it was conceivable that
prolonged exposure at physiological temperature might induce cross-linking and redistribution of the exchangers, possibly altering their number at the plasmalemma. To rule out this possibility, AP1/NHE3'38HA3 cells were incubated with anti-HA antibody
for 30 min at 37 °C, thereby allowing endocytosis to proceed. The activity of NHE3 was measured subsequently, as described above. This
pretreatment had no significant effect on the rate of
Na+/H+ exchange (Fig. 1C,
trace 3), suggesting that the overall distribution of NHE3
was unaltered, a conclusion consistent with the morphological determinations reported in Fig. 1, A and B. In
summary, our data imply that neither the introduction of the external
HA-tag nor binding of monoclonal antibody to the external epitope had
any effect on the subcellular distribution or activity of NHE3.
Time Course of Internalization of NHE3--
To study the route of
internalization used by NHE3, it was important to define its normal
time course of endocytosis. Initial determinations were made by
immunofluorescence methods that involved labeling the surface-exposed
exchangers in the cold using anti-HA antibody and then allowing
internalization upon rewarming. After varying times, the cells were
fixed, permeabilized, and stained with labeled secondary antibodies.
Typical results are shown in Fig. 2,
A-C. As expected, only superficial NHE3 molecules were labeled in the cold, whereas progressive internalization and
juxtanuclear accumulation occurred upon warming. The process was
clearly detectable by 20 min and neared completion by 40 min.
To more quantitatively evaluate the process of internalization, cells
were labeled in the cold as above and, after warming to 37 °C for
the indicated periods, the fraction of antibody remaining at the
surface was quantified using I125-labeled secondary
antibody. As summarized in Fig. 2D, over 50% of the HA
antibody bound initially had disappeared after 20 min at 37 °C, and
over 80% was missing after 40 min. Disappearance of the antibody was
due to internalization, rather than dissociation or degradation. This
was demonstrated by fixing and permeabilizing the cells prior to
addition of the secondary antibody (not shown). Jointly, these
experiments show that NHE3 becomes internalized with a half-life of
under 20 min.
Effects of Hypertonicity, Intracellular Acidification, and
K+ Depletion on Internalization of NHE3--
The possible
role of clathrin-mediated endocytosis (CME) in NHE3 internalization was
evaluated next. As an initial approach, we used several maneuvers
reported earlier to effectively impair clathrin-mediated endocytosis.
These included cell shrinkage by prolonged elevation of the medium
osmolarity (35, 44), acidification of the cytosol (35), and depletion
of intracellular K+ (35, 36).
Fig. 3 shows experiments comparing the
extent of NHE3 internalization in isotonic (Iso) and
hypertonic (Hyp) media. In accordance with the results
above, the surface antiporters are largely internalized after 45 min at
37 °C under physiological isotonic conditions (A and
B in Fig. 3). By contrast, most of the exchangers remained at the cell surface when the cells were rewarmed in hypertonic medium
(Fig. 3C). As before, we could quantify these effects using radiolabeled secondary antibody. The results of nine experiments are
summarized in D of Fig. 3. Only 35 ± 5% of the
antibody initially bound to NHE3 was found at the surface after 45 min
under isotonic conditions, whereas virtually all of the original NHE3
remained at the plasma membrane in the hypertonically treated cells
(Fig. 3D).
Similar results were obtained in cells subjected to two other
treatments that block CME, namely cytosolic acidification by incubation
in acetate-rich medium of low pH and K+ depletion,
accomplished by a combination of hypotonic stress and incubation in
K+-free medium (data not shown). The cumulative evidence
indicates that inhibition of CME by physicochemical means precludes
internalization of NHE3.
Inhibition of Endocytosis Using a Dynamin Mutant, Effect on
NHE3'38HA3 Internalization--
Because the physical
treatments used above are comparatively harsh, they are likely to have
additional effects that are unrelated to inhibition of clathrin coat
formation. In order to study the involvement of clathrin in NHE3
internalization more precisely, we used a more selective means to
inhibit CME. Specifically, we prevented the fission of clathrin-coated
pits from the plasma membrane using an inhibitory form of dynamin.
Dynamin is a 100-kDa GTPase that has been found to be essential for
CME. After being recruited to clathrin-coated pits by interactions
involving its COOH-terminal proline-rich region, multiple dynamin
monomers arrange into a helical structure at the neck of the coated
pits. Upon hydrolysis of GTP, dynamin severs the pits from the plasma
membrane, releasing clathrin-coated vesicles (see Refs. 45 and 46 for reviews). Dominant-negative mutant forms of dynamin I, which lack GTPase activity, can bind to the coated pits yet fail to effect fission
of coated vesicles and thereby block CME (47, 48).
To verify the role of clathrin in NHE3 internalization, we used a
mutant form of dynamin I where Ser-45 has been mutated to Asn (DynS45N)
and which was shown earlier to exert a dominant-negative effect (47,
48). To verify the inhibitory effect of DynS45N, we tested whether
transient transfection of this dominant-negative mutant was able to
prevent the internalization of Tfn receptors, which are exclusively
internalized via CME (28, 30). Cells transfected with DynS45N were
identified by co-transfection with enhanced-GFP (EGFP), while the
internalization of the receptor was assessed using rhodamine-conjugated
human Tfn. As illustrated in Fig.
4B, whereas Tfn was readily
accumulated in pericentriolar recycling endosomes in nontransfected
cells, little Tfn was internalized by cells expressing DynS45N
(indicated by an arrow). Importantly, the mutant dynamin
also impaired the internalization of NHE3 (Fig. 4, C and
D).
Taken together, the experiments using hypertonicity, acidity, or
cytosolic K+ depletion and those using transfection of
dominant-negative constructs of dynamin indicate that endocytosis of
NHE3 occurs predominantly through clathrin-mediated vesiculation.
Colocalization of NHE3 with Clathrin Coat Components in Epithelial
Cells--
While the preceding experiments strongly implicate
clathrin-dependent endocytosis in the internalization of
NHE3 in AP-1 cells, it is unclear whether these findings in
heterologous transfectants can be extrapolated to native epithelial
cells. We therefore undertook fractionation studies in an attempt to
define whether NHE3 is localized in clathrin-coated vesicles in
intestinal epithelial cells.
Purification and identification of CCV from several tissues using a
method of differential centrifugation and cell fractionation is well
documented (38). We used this procedure to isolate CCV from absorptive
villus cells of the rabbit ileum, which have previously been shown to
express high levels of NHE3 (11). To validate the effectiveness of the
isolation procedure, we also isolated liver CCV, which are readily
purified by this method (38). CCV isolated from the liver and the ileum
were separated by SDS-polyacrylamide gel electrophoresis and the gel
stained with Coomassie Blue. As shown in Fig.
5A, the major proteins
detected in both preparations were similar and had sizes that were
compatible with those of the clathrin heavy chain, the clathrin light
chain, and the adaptor proteins. This protein pattern is similar to
that of CCV isolated from adipocytes, which also contain the glucose
transporter, GLUT-4 (49). To confirm the presence of the coat proteins
in our preparations, CCV from the liver and from isolated ileal cells
were separated by SDS-polyacrylamide gel electrophoresis, transferred
to nitrocellulose, and immunoblotted with monoclonal antibodies to the
clathrin heavy chain and to the adaptor proteins 1 and 2 (AP-1 and
AP-2, respectively). As shown in Fig. 5B, all of these coat
proteins were found in the CCV isolated from both the liver and the
intestine. To determine whether they also contained NHE3, CCV from
intestinal cells were subjected to immunoblotting using a monoclonal
antibody to NHE3. A protein extract of isolated brush border membranes
from rabbit ileum was used to confirm the effectiveness of the
antibody. As shown in Fig. 5C, NHE3 was present not only in
the brush border membranes, but in the ileal CCV as well. We also found
that NHE3 and the CCV markers became enriched in parallel during the
purification procedure (not illustrated). These data indicate that NHE3
co-purifies with CCV in native tissues where it is endogenously
expressed, complementing the observations in heterologous
transfectants.
Role of COP-I in Intracellular Traffic of NHE3--
Once
internalized, the contents of early endosomes are sorted to different
compartments. Some components proceed to late endosomes and eventually
to lysosomes, where they can be degraded. Other endosomal proteins and
lipids travel retrogradely to the trans-Golgi network, while
yet others return to the plasma membrane via recycling endosomes (see
Ref. 30 for review). Routing of endosomal constituents to their
appropriate destinations depends, at least in part, on members of the
COP family of coat proteins (50, 51). A distinct subset of COP-I
proteins, which includes the
We took advantage of the inducible nature of the mutation in
ldlF cells to define the role of The present results confirm our earlier observation that, in
AP-1-derived CHO cells, NHE3 accumulates in recycling endosomes. Recycling endosomes of nonepithelial cells were recently suggested to
be analogous to apical recycling endosomes in polarized cells (54),
where endogenous NHE3 is expressed (16). This conclusion was based on
studies of Rab17, a small GTPase that is highly localized to apical
recycling endosomes in epithelial cells. When ectopically expressed in
nonpolarized fibroblasts, Rab17 was found to be localized in the
pericentriolar recycling endosomes (54), where NHE3 also accumulates.
These observations validate the use of the nonpolarized CHO cells as an
adequate model to study the internalization of the epithelial NHE3.
A central role of CME in the internalization and recycling of NHE3 is
suggested by the inhibitory effects of DynS45N. This dominant-negative
form of dynamin effectively prevented the endocytosis of NHE3. While
elegant and specific, the transfection experiments require
comparatively long periods of incubation. Under these conditions,
compensatory mechanisms such as induction of non-clathrin-coated vesicles may be up-regulated (47, 48), in order to ensure cell
survival. Moreover, dynamin is also involved in other endocytic processes. Internalization of some glycosylphosphoinositol-linked membrane proteins and bacterial toxins occurs mainly through caveolae, small flask-shaped non-clathrin-coated plasmalemmal vesicles (55-57). Like clathrin-coated pits, fission of caveolae from the membrane to
form free endocytic vesicles requires GTP hydrolysis and was recently
found to involve dynamin (29, 58). Ultrastructural and biochemical
analyses have revealed dynamin to associate directly with caveolae
where, as found in clathrin-coated pits, it assembles at the neck.
Functional data with inhibitory antibodies and with dominant-negative
dynamin mutants revealed that the GTPase activity of dynamin is crucial
for budding of caveolae (29, 58). For these reasons, transfection with
DynS45N is not conclusive evidence of involvement of CME in NHE3 internalization.
In this context, physicochemical maneuvers, such as depletion of
intracellular K+ or prolonged treatment of the cells with
hypertonic or acidic solutions, provide useful complementary
information. Although less specific than transfection, these procedures
are not believed to affect caveolae or other noncoated internalization
pathways and have been used extensively to inhibit CME in a variety of cell types (e.g. Refs. 35, 36, and 59). In CHO cells, they effectively prevented the uptake of Tfn, a hallmark of CME, and they
similarly inhibited the internalization of NHE3. Jointly, these
approaches support the notion that CME is the predominant pathway for
NHE3 internalization, at least in heterologous transfectants.
Importantly, subcellular fractionation studies suggested that native
NHE3 is also internalized via CME in epithelial cells. As summarized in
Fig. 5, a fraction of the NHE3 isolated from intestinal epithelial
cells was found to co-purify with clathrin-coated vesicles. Together
with the molecular and physicochemical approaches described above,
these observations argue in favor of CME as an important route for NHE3 endocytosis.
Internalization of plasmalemmal transporters is important not only for
their catabolism, but in some instances also as a regulator of the
number of active transporters at the membrane. Constitutive internalization of the epithelial sodium channel by CME has recently been shown to be important for regulating its activity both in vivo and in cell culture (60). In this system, overexpression of a
dominant-negative dynamin resulted in stimulation of channel activity,
mimicking the functional phenotype of Liddle's syndrome (60).
Internalization of transporters is also important in the termination of
the stimulatory effects of insulin on glucose transport (61) and of
acid secretion in the stomach (62).
By analogy, modulation of CME may play a role in regulation of NHE3
activity. This hypothesis is lent credence by the observations that
NHE3 activity increases in response to prolonged hyperosmolarity and
acidity, both of which are potent inhibitors of CME (44, 63, 64). The
stimulation of transport is associated with increased number of
exchangers, with little increase in mRNA, ruling out de
novo NHE3 synthesis (22, 23, 65). It is tempting to speculate that
reduced internalization leads to accumulation of plasmalemmal exchangers and contributes to the stimulation of transport. Conversely, earlier subcellular fractionation studies concluded that a net displacement of antiporters from the plasma membrane to the endosomal pool of renal cells mediates the inhibitory effects of parathyroid hormone and hypertension on NHE3 (20, 21, 66). Likewise, the acute
inhibition of NHE3 activity induced by protein kinase C in colonic
epithelial cells was attributed to a redistribution of exchanger
molecules from the brush border into a subapical cytoplasmic
compartment (67).
Contrary to the involvement of clathrin-coated pits and vesicles,
In summary, we have shown that CME contributes to the physiological
internalization of NHE3 and that intracellular traffic of NHE3 involves
components of the COP-I co-atomer. Ongoing studies aimed at identifying
the motifs that target NHE3 to clathrin-coated pits will shed
additional light on the role of recycling in the function and
regulation of this isoform of the Na+/H+ exchanger.
-COP subunit. At the permissive temperature, NHE3 distributed
normally, whereas at the restrictive temperature, which induces rapid
degradation of
-COP, NHE3 was still internalized, but its
subcellular distribution was altered. These results indicate that
endocytosis of NHE3 occurs primarily via clathrin-coated pits and
vesicles and that normal intracellular trafficking of NHE3 involves an
-COP-dependent step.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-COP that is expressed only at the
restrictive temperature (
39 °C) but not at permissive temperatures
(
34 °C) (32-34).
-minimal essential medium (Ontario Cancer Institute, Toronto,
Ontario, Canada) containing 25 mM NaHCO3 and
supplemented with 10% fetal calf serum, 100 units/ml penicillin and
100 µg/ml streptomycin (Life Technologies, Inc.). AP-1 cells were
incubated in a humidified environment containing 95% air and 5%
CO2 at 37 °C. ldlF cells were grown at
34 °C. To induce the mutant
-COP phenotype, these cells were
incubated at 39 °C for 8-12 h prior to assay. Cultures were
re-established from frozen stocks regularly and cells from passages 3 to 20 were used for the experiments.
E. coli, grown in Luria broth with the
appropriate selection antibiotics, and purified using commercially
available kits (Qiagen Maxiprep, Qiagen, Mississauga, Ontario, Canada).
counter. Data were analyzed
using Microcal OriginTM and are presented as means ± S.E.
Significance was assessed using Student's t test.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (48K):
[in a new window]
Fig. 1.
Binding of antibody to the HA epitope has no
effect on NHE3 distribution or activity.
AP1/NHE3'38HA3 cells grown to subconfluence on 25-mm glass
coverslips were used for immunofluorescence or pHi
determinations, as described under "Experimental Procedures."
A, the cells were fixed, permeabilized, and then incubated
with 1/1000 anti-HA antibody, followed by Cy3-conjugated anti-mouse IgG
(1/1000). B, live cells were incubated with 1/1000 anti-HA
antibody, and endocytosis was allowed to proceed by incubation at
37 °C for 45 min. Unbound antibody was removed by extensive washing
with ice-cold PBS, and the cells were next fixed, permeabilized, and
labeled with secondary antibody as in A. C, the
Na+/H+ exchange activity of NHE3 was estimated
by microfluorimetric measurement of pHi using BCECF after an
acute NH4Cl-induced acid load. Otherwise, untreated cells
(trace 1 and diagram 1) were compared with cells
that had been incubated with anti-HA antibody (1/500) for either 30 min
at 4 °C, resulting in binding to surface NHE3 (trace 2 and diagram 2) or with the same concentration of antibody
for 30 min at 37 °C, to induce internalization of the antibody-NHE3
complex (trace 3 and diagram 3). Images and
traces are representative of at least three individual experiments of
each kind.

View larger version (108K):
[in a new window]
Fig. 2.
Time course of internalization of NHE3.
A-C, AP1/NHE3'38HA3 cells were cooled to
4 °C by washing in ice-cold PBS and incubated with anti-HA antibody
(1/1000) for 1 h at 4 °C. Unbound antibody was removed by
washing with ice-cold PBS. The cells were then incubated for the
indicated periods of time at 37 °C, fixed, and permeabilized.
Finally, the cells were stained with Cy3-conjugated secondary antibody
before visualization by epifluorescence. D, for quantitation
of surface NHE3, AP1/NHE3'38HA3 cells grown on six-well
plates were labeled with anti-HA antibody as in A-C.
Internalization was allowed to occur by incubation for the specified
periods at 37 °C and terminated by extensive washes with ice-cold
PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2. After blocking for 1 h at
4 °C with buffer supplemented with 10% goat serum, the cells were
labeled with 0.8 µCi/ml labeled 125I-sheep
anti-mouse IgG for 1 h at 4 °C. Unbound 125I-IgG
was removed by extensive washing, the cells were eluted from the plate
with 2 M formic acid, and radioactivity was counted. Cells
exposed to the 125I-IgG without preincubation with anti-HA
antibody were used to determine nonspecific binding, which was
subtracted from all determinations. Data are representative of three
separate experiments, each with triplicate determinations. Normalized
to the initial binding and presented as mean ± S.E.

View larger version (81K):
[in a new window]
Fig. 3.
Effect of hypertonicity on internalization of
NHE3. A-C, immunofluorescence of
AP1/NHE3'38HA3 cells grown on glass coverslips. Anti-HA
antibody was bound to the cell surface in the cold as in Fig. 2,
followed by incubation at 37 °C in isotonic (Iso) medium
for 0 or 45 min (A and B, respectively) or for 45 min in hypertonic (Hyp) solution (normal medium supplemented
with 0.45 M sucrose; C). The cells were then
fixed, permeabilized, and subjected to immunostaining with
Cy3-conjugated anti-mouse antibody as in Fig. 2. Images are
representative of at least three similar experiments. D,
cells were allowed to bind anti-HA antibody in the cold and were then
incubated in isotonic or hypertonic solution as in A-C.
Last, surface-exposed anti-HA antibody was quantified using
I125-labeled sheep anti-mouse IgG as in Fig. 2D.
Data are representative of three separate experiments, each with
triplicate determinations. Normalized to the initial binding and
presented as mean ± S.E.

View larger version (75K):
[in a new window]
Fig. 4.
Effect of dominant-negative dynamin DynS45N
on endocytosis of Tfn and NHE3. AP1/NHE3'38HA3 cells
were transiently transfected with cDNA encoding DynS45N and EGFP at
a 10:1 ratio. The effects of DynS45N on Tfn receptor recycling
(A and B) and on NHE3 internalization
(C and D) were assessed 24-36 h after
transfection. A and C, transfected cells
identified by EGFP fluorescence (arrow). B,
internalization of Tfn by the cells shown in A. D, internalization of NHE3, assessed after 45 min as in Fig.
2. Representative fields of three separate experiments.

View larger version (33K):
[in a new window]
Fig. 5.
Co-purification of NHE3 with clathrin-coated
vesicles in epithelial cells. A, protein composition of
CCV-enriched fraction from ileal villus cells (left) and
from liver cells (right). Aliquots of liver and intestinal
cells were separated on a 12% SDS-polyacrylamide gel and stained with
Coomassie Blue. The position where adaptor proteins, and the clathrin
heavy and light chains are expected to migrate is indicated on the
right. B, CCV-enriched preparations from liver and ileal
villus cells (1 and 2.5 µg protein each, respectively) were subjected
to immunoblotting with antibody to the heavy chain of clathrin
(top), the adaptor protein AP-1 (middle), or AP-2
(bottom panel). C, left lane: a
CCV-enriched preparation from ileal villus cells was immunoblotted with
antibody to the heavy chain of clathrin (top) or to NHE3
(2.5 and 5 µg protein, respectively). Right lane: an ileal
brush-border preparation was immunoblotted with anti-NHE3 antibody. The
results in A-C are representative of five
experiments.
,
,
', and
subunits, was
found to associate with early endosomes (50), where it plays a role in
endosomal maturation. For example, cellular microinjection of an
antibody to
-COP interfered with delivery of cargo from early to
late endosomes (50). Additional evidence of a role of COP-I in
endosomal traffic was obtained using ldlF cells, a line
derived from CHO cells which bears a temperature-sensitive mutation in
-COP (32-34, 52, 53). At permissive temperatures (
34 °C),
ldlF cells express reduced levels of
-COP, which
nevertheless suffice for normal COP-I function. As the temperature is
raised to nonpermissive levels (
39 °C),
-COP becomes unstable
and is rapidly degraded (33). As a result, endosomal traffic is
affected: recycling is partially inhibited and delivery of carrier
vesicles from early to late endosomes is blocked (33, 53).
-COP in the uptake and
intracellular traffic of NHE3. NHE3'38HA3 was transiently
transfected into ldlF cells grown at 34 °C, a permissive
temperature. As shown in Fig. 6C, the distribution of the
exchangers expressed transiently in cells maintained at 34 °C was
similar to that of the wild-type stable transfectants used above. After
allowing transient expression at 34 °C, some of the cells were
warmed to 39 °C for 8-12 h and the distribution of NHE3 was
evaluated again. Elimination of
-COP, which was verified by
immunoblotting (not shown), did not prevent internalization of NHE3
(Fig. 6D). However, the intracellular distribution of NHE3
seemed to be somewhat affected, with reduced juxtanuclear
concentration. In most cells, comparatively large vesicles containing
NHE3 were scattered throughout the cell. This pattern resembles the
distribution of Tfn receptors, which were similarly internalized
normally at 34 °C, but scattered into larger structures at 39 °C
(not illustrated). These findings confirm that, in CHO cells, NHE3 is
distributed in a compartment which strongly resembles that occupied by
Tfn receptors. Moreover, they indicate that whereas
-COP is not
essential for internalization of the antiporters, this COP-I component
affects the normal intracellular traffic of NHE3.

View larger version (71K):
[in a new window]
Fig. 6.
Effect of
-COP
mutants on NHE3 distribution. ldlF cells grown at
34 °C were transiently transfected with vectors encoding
NHE3'38HA3 and EGFP at a 10:1 ratio. Twenty-four hours
after transfection the cells were incubated for a further 8-12 h at
either a permissive temperature (34 °C) or at a restrictive
temperature (39 °C). Next, the cells were cooled to 4 °C by
washing in ice-cold PBS and incubated with anti-HA antibody (1/1000)
for 1 h at 4 °C. Unbound antibody was removed by washing with
ice-cold PBS. The cells were then incubated for the indicated periods
of time at 37 °C, fixed, and permeabilized. Finally, the cells were
stained with Cy3-conjugated secondary antibody before visualization by
epifluorescence. A and B, fluorescence of EGFP.
C and D, immunostaining of the HA epitope,
indicating the distribution of NHE3. Representative of three separate
experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-COP was seemingly not required for NHE3 internalization, suggesting
that COP-I-coated vesicles were not essential. However, genetic
ablation of
-COP in the temperature-sensitive ldlF
mutants modified the appearance of the intracellular compartment where NHE3 resides. These findings are compatible with those of those of Daro
et al. (53) who showed redistribution of endomembranes and
partial inhibition of Tfn receptor recycling in ldlF cells grown at the restrictive
temperature.2 We
suggest that normal traffic of NHE3 along the endocytic pathway requires COP-I. Future experiments will be required to ascertain whether the normal complement of NHE3 at the surface membrane is
affected in
-COP-deficient cells. Quantitation of the number of
transporters or their activity was not performed in the present experiments in view of the wide variability of expression in transient transfectants.
| |
FOOTNOTES |
|---|
* This work was supported by the Medical Research Council of Canada and the Kidney Foundation of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Industry Research Scholar. Supported by the American Digestive
Health Foundation of the United States.
** International Scholar of the Howard Hughes Medical Institute and is the current holder of the Pitbaldo Chair in Cell Biology at the Hospital for Sick Children. Cross-appointed to the Department of Biochemistry, University of Toronto.
§§ Medical Research Council of Canada Scientist. To whom correspondence should be addressed: Dept. of Physiology, McGill University, McIntyre Medical Science Bldg., 3655 Drummond St., Montreal, Quebec H3G 1Y6, Canada. Tel.: 514-398-8335; Fax: 514-398-7452; E-mail: orlowski@med.mcgill.ca.
2 Our observations and those of Daro et al. (53) are, however, different from those of Gu et al. (52) who showed no difference in Tfn receptor traffic in ldlF cells incubated at 40 °C. The source of this apparent inconsistency is not apparent, but may relate to the short uptake periods used by the latter group.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NHE, Na+/H+ exchanger; BCECF, 2'7'-bis-(2-carboxyethyl)-5(and 6)-carboxyfluorescein; CCV, clathrin-coated vesicles; CHO, Chinese hamster ovary; CME, clathrin-mediated endocytosis; DynS45N, dominant-negative S45N mutant of dynamin; EGFP, enhanced green fluorescent protein; HA, hemagglutinin epitope; PBS, phosphate-buffered saline; Tfn, transferrin; MES, 4-morpholineethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Orlowski, J.,
and Grinstein, S.
(1997)
J. Biol. Chem.
272,
22373-22376 |
| 2. |
Wang, Z.,
Orlowski, J.,
and Shull, G. E.
(1993)
J. Biol. Chem.
268,
11925-11928 |
| 3. |
Orlowski, J.,
Kandasamy, R. A.,
and Shull, G. E.
(1992)
J. Biol. Chem.
267,
9331-9339 |
| 4. |
Brant, S. R.,
Yun, C. H.,
Donowitz, M.,
and Tse, C. M.
(1995)
Am. J. Physiol.
269,
C198-C206 |
| 5. | Cox, G. A., Lutz, C. M., Yang, C. L., Biemesderfer, D., Bronson, R. T., Fu, A., Aronson, P. S., Noebels, J. L., and Frankel, W. N. (1997) Cell 91, 139-148[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Schultheis, P. J.,
Clarke, L. L.,
Meneton, P.,
Harline, M.,
Boivin, G. P.,
Stemmermann, G.,
Duffy, J. J.,
Doetschman, T.,
Miller, M. L.,
and Shull, G. E.
(1998)
J. Clin. Invest.
101,
1243-1253 |
| 7. | Schultheis, P. J., Clarke, L. L., Meneton, P., Miller, M. L., Soleimani, M., Gawenis, L. R., Riddle, T. M., Duffy, J. J., Doetschman, T., Wang, T., Giebisch, G., Aronson, P. S., Lorenz, J. N., and Shull, G. E. (1998) Nat. Genet. 19, 282-285[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Bookstein, C., DePaoli, A., Xie, Y., Niu, P., Musch, M. W., Rao, M. C., and Chang, E. B. (1994) J. Clin. Invest. 93, 106-113 |
| 9. |
Yoshioka, S.,
Suzuki, T.,
and Kawakita, M.
(1997)
J. Biochem. (Tokyo)
122,
641-646 |
| 10. |
Soleimani, M.,
Singh, G.,
Bizal, G. L.,
Gullans, S. R.,
and McAteer, J. A.
(1994)
J. Biol. Chem.
269,
27973-27978 |
| 11. |
Wormmeester, L.,
Sanchez de Medina, F.,
Kokke, F.,
Tse, C. M.,
Khurana, S.,
Bowser, J. M.,
Cohen, M. E.,
and Donowitz, M.
(1998)
Am. J. Physiol.
274,
C1261-C1272 |
| 12. | Guerra, L., Di Sole, F., Valenti, G., Ronco, P. M., Perlino, E., Casavola, V., and Reshkin, S. J. (1998) Kidney Int. 53, 1269-1277[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Noel, J., Roux, D., and Pouyssegur, J. (1996) J. Cell Sci. 109, 929-939[Abstract] |
| 14. | Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., and Bowtell, D. (1993) Nature 363, 83-85[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Amemiya, M., Loffing, J., Lotscher, M., Kaissling, B., Alpern, R. J., and Moe, O. W. (1995) Kidney Int. 48, 1206-1215[Medline] [Order article via Infotrieve] |
| 16. |
Biemesderfer, D.,
Rutherford, P. A.,
Nagy, T.,
Pizzonia, J. H.,
Abu-Alfa, A. K.,
and Aronson, P. S.
(1997)
Am. J. Physiol.
273,
F289-F299 |
| 17. |
Sabolic, I.,
and Brown, D.
(1990)
Am. J. Physiol.
258,
F1245-F1253 |
| 18. |
Hilden, S. A.,
Ghoshroy, K. B.,
and Madias, N. E.
(1990)
Am. J. Physiol.
258,
F1311-F1319 |
| 19. |
van Dyke, R. W.
(1995)
Am. J. Physiol.
269,
C943-C954 |
| 20. |
Zhang, Y.,
Mircheff, A. K.,
Hensley, C. B.,
Magyar, C. E.,
Warnock, D. G.,
Chambrey, R.,
Yip, K. P.,
Marsh, D. J.,
Holstein-Rathlou, N. H.,
and McDonough, A. A.
(1996)
Am. J. Physiol.
270,
F1004-F1014 |
| 21. |
Zhang, Y.,
Norian, J. M.,
Magyar, C. E.,
Holstein-Rathlou, N. H.,
Mircheff, A. K.,
and McDonough, A. A.
(1999)
Am. J. Physiol.
276,
F711-F719 |
| 22. |
Laghmani, K.,
Borensztein, P.,
Ambuhl, P.,
Froissart, M.,
Bichara, M.,
Moe, O. W.,
Alpern, R. J.,
and Paillard, M.
(1997)
J. Clin. Invest.
99,
24-30 |
| 23. |
Ambuhl, P.,
Amemiya, M.,
Danczkay, M.,
Lotscher, M.,
Kaissling, B.,
Moe, O. W.,
Preisig, P. A.,
and Alpern, R. J.
(1996)
Am. J. Physiol.
271,
F917-F925 |
| 24. | Bloch, D. R., Zikos, D., Fisher, K. A., Sukowski, E. J., Cragoe, E. J., and Peterson, D. R. (1993) Contrib. Nephrol. 101, 19-25[Medline] [Order article via Infotrieve] |
| 25. |
D'Souza, S.,
Garcia-Cabado, A., Yu, F.,
Moore, H.-P.,
Teter, K.,
Lukacs, G.,
Skorecki, K.,
Orlowski, J.,
and Grinstein, S.
(1998)
J. Biol. Chem.
273,
2035-2043 |
| 26. |
Kurashima, K.,
Szabo, E. Z.,
Lukacs, G.,
Orlowski, J.,
and Grinstein, S.
(1998)
J. Biol. Chem.
273,
20828-20836 |
| 27. | Robinson, M. S. (1994) Curr. Opin. Cell Biol. 6, 538-544[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Mukherjee, S.,
Ghosh, R. N.,
and Maxfield, F. R.
(1997)
Physiol. Rev.
77,
759-803 |
| 29. |
Oh, P.,
McIntosh, D. P.,
and Schnitzer, J. E.
(1998)
J. Cell Biol.
141,
101-114 |
| 30. | Mellman, I. (1996) Annu. Rev. Cell Dev. Biol. 12, 575-625[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Rotin, D., and Grinstein, S. (1989) Am. J. Physiol. 267, C1158-C1165 |
| 32. |
Hobbie, L.,
Fisher, A. S.,
Lee, S.,
Flint, A.,
and Krieger, M.
(1994)
J. Biol. Chem.
269,
20958-20970 |
| 33. |
Guo, Q.,
Penman, M.,
Trigatti, B.,
and Krieger, M.
(1996)
J. Biol. Chem.
271,
11191-11196 |
| 34. |
Guo, Q.,
Vasile, E.,
and Krieger, M.
(1994)
J. Cell Biol.
125,
1213-1224 |
| 35. |
Hansen, S. H.,
Sandvig, K.,
and van Deurs, B.
(1993)
J. Cell Biol.
121,
61-72 |
| 36. | Larkin, J. M., Brown, M. S., Goldstein, J. L., and Anderson, R. G. W. (1983) Cell 33, 273-285[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Campbell, C., Squicciarini, J., Shia, M., Pilch, P. F., and Fine, R. E. (1984) Biochemistry 23, 4420-4426[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Linder, R. (1994) in Cell Biology: A Laboratory Handbook (Cells, J. E., ed) , pp. 525-530, Academic Press, New York |
| 39. | Pearse, B. M. (1989) Methods Cell Biol. 31, 229-246[Medline] [Order article via Infotrieve] |
| 40. |
Weiser, M. M.
(1973)
J. Biol. Chem.
248,
2536-2541 |
| 41. | Khurana, S., Kreydiyyeh, S., Aronzon, A., Hoogerwerf, W. A., Rhee, S. G., Donowitz, M., and Cohen, M. E. (1996) Biochem. J. 313, 509-518 |
| 42. |
Chow, C. W.,
Kapus, A.,
Romanek, R.,
and Grinstein, S.
(1997)
J. Gen. Physiol.
110,
185-200 |
| 43. | Thomas, J. A., Buchsbaum, R. N., Zimniak, A., and Racker, E. (1979) Biochemistry 18, 2210-2218[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Heuser, J. E.,
and Anderson, R. G.
(1989)
J. Cell Biol.
108,
389-400 |
| 45. | Damke, H. (1996) FEBS Lett. 389, 48-51[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Urrutia, R.,
Henley, J. R.,
Cook, T.,
and McNiven, M. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
377-384 |
| 47. |
Damke, H.,
Baba, T.,
van der Bliek, A. M.,
and Schmid, S. L.
(1995)
J. Cell Biol.
131,
69-80 |
| 48. |
Damke, H.,
Baba, T.,
Warnock, D. E.,
and Schmid, S. L.
(1994)
J. Cell Biol.
127,
915-934 |
| 49. |
Chakrabarti, R.,
Buxton, J.,
Joly, M.,
and Corvera, S.
(1994)
J. Biol. Chem.
269,
7926-7933 |
| 50. | Whitney, J. A., Gomez, M., Sheff, D., Kreis, T. E., and Mellman, I. (1995) Cell 83, 703-713[CrossRef][Medline] [Order article via Infotrieve] |
| 51. |
Aniento, F.,
Gu, F.,
Parton, R. G.,
and Gruenberg, J.
(1996)
J. Cell Biol.
133,
29-41 |
| 52. |
Gu, F.,
Aniento, F.,
Parton, R. G.,
and Gruenberg, J.
(1997)
J. Cell Biol.
139,
1183-1195 |
| 53. |
Daro, E.,
Sheff, D.,
Gomez, M.,
Kreis, T. E.,
and Mellman, I.
(1997)
J. Cell Biol.
139,
1747-1759 |
| 54. |
Zacchi, P.,
Stenmark, H.,
Parton, R. G.,
Orioli, D.,
Lim, F.,
Giner, A.,
Mellman, I.,
Zerial, M.,
and Murphy, C.
(1998)
J. Cell Biol.
140,
1039-1053 |
| 55. | Kurzchalia, T. V., and Parton, R. G. (1996) FEBS Lett. 389, 52-54[CrossRef][Medline] [Order article via Infotrieve] |
| 56. | Parton, R. G. (1996) Curr. Opin. Cell Biol. 8, 542-548[CrossRef][Medline] [Order article via Infotrieve] |
| 57. |
Tiruppathi, C.,
Song, W.,
Bergenfeldt, M.,
Sass, P.,
and Malik, A. B.
(1997)
J. Biol. Chem.
272,
25968-25975 |
| 58. |
Henley, J. R.,
Krueger, E. W. A.,
Oswald, B.,
and McNiven, M. A.
(1998)
J. Cell Biol.
141,
85-99 |
| 59. |
Hansen, S. H.,
Sandvig, K.,
and van Deurs, B.
(1993)
J. Cell Biol.
123,
89-97 |
| 60. |
Shimkets, R. A.,
Lifton, R. P.,
and Canessa, C. M.
(1997)
J. Biol. Chem.
272,
25537-25541 |
| 61. |
Volchuk, A.,
Narine, S.,
Foster, L. J.,
Grabs, D.,
De Camilli, P.,
and Klip, A.
(1998)
J. Biol. Chem.
273,
8169-8176 |
| 62. | Dunbar, L. A., Courtois-Coutry, N., Roush, D. L., Muth, T. R., Gottardi, C. J., Rajendran, V., Geibel, J., Kashgarian, M., and Caplan, M. J. (1998) Acta Physiol. Scand. Suppl. 643, 289-295 |
| 63. |
Heuser, J.
(1989)
J. Cell Biol.
108,
401-411 |
| 64. | Davoust, J., Gruenberg, J., and Howell, K. E. (1987) EMBO J. 6, 3601-3609[Medline] [Order article via Infotrieve] |
| 65. |
Amemiya, M.,
Yamaji, Y.,
Cano, A.,
Moe, O. W.,
and Alpern, R. J.
(1995)
Am. J. Physiol.
269,
C126-C133 |
| 66. |
Hensley, C. B.,
Bradley, M. E.,
and Mircheff, A. K.
(1989)
Am. J. Physiol.
257,
C637-C645 |
| 67. |
Janecki, A. J.,
Montrose, M. H.,
Zimniak, P.,
Zweibaum, A.,
Tse, C. M.,
Khurana, S.,
and Donowitz, M.
(1998)
J. Biol. Chem.
273,
8790-8798 |
This article has been cited by other articles:
![]() |
D. S. Muller, P. Houpert, J. Cambar, and M.-H. Henge-Napoli Role of the Sodium-Dependent Phosphate Cotransporters and Absorptive Endocytosis in the Uptake of Low Concentrations of Uranium and Its Toxicity at Higher Concentrations in LLC-PK1 Cells Toxicol. Sci., February 1, 2008; 101(2): 254 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai, L. Wu, W. Qu, D. Malhotra, Z. Xie, J. I. Shapiro, and J. Liu Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex |